Dr. Lilja holds an MSc in chemical engineering from Chalmers University of Technology, Sweden, a PhD in biochemistry from University of Maryland, and did postdoctoral training in molecular virology at Princeton University. He has co-authored several publications characterizing key cytomegalovirus vaccine antigens.
vaccine